Sale!

CYP2C19 Genotyping Test Cost

Original price was: 2,060 د.إ.Current price is: 1,850 د.إ.

-10%

The CYP2C19 Genotyping Test is a specialized genetic test conducted to analyze the CYP2C19 gene, which plays a crucial role in drug metabolism. This test is particularly significant for determining how individuals metabolize various medications, including antiplatelet drugs, antidepressants, and proton pump inhibitors. By identifying specific genetic variants, healthcare providers can tailor medication types and dosages to enhance treatment efficacy and minimize adverse drug reactions. The test is available at DNA Labs UAE, a leading facility in genetic testing, ensuring high-quality and accurate results. The cost of the CYP2C19 Genotyping Test at DNA Labs UAE is 1850 AED, making it a valuable investment for personalized medicine and optimal therapeutic outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CYP2C19 GENOTYPING Test

Test Name: CYP2C19 GENOTYPING Test

Components: CYP2C19 gene analysis

Price: 1850.0 AED

Sample Condition: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.

Report Delivery: SampleSat by 11 am; Report 15 Working days

Method: PCR, Sequencing

Test type: Pharmacogenomics

Doctor: Physician

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

What is the CYP2C19 genotyping test?

The CYP2C19 genotyping test is a genetic test that determines an individual’s specific genetic variations in the CYP2C19 gene. This gene encodes an enzyme that is responsible for metabolizing various drugs, including antiplatelet agents, antidepressants, and proton pump inhibitors.

Why is the test performed?

The test is usually performed to identify individuals who may have variations in the CYP2C19 gene, which can affect how they metabolize certain medications. These genetic variations can result in either decreased or increased enzyme activity, leading to variations in drug response and potential adverse effects.

How is the test conducted?

The CYP2C19 genotyping test is typically done using a sample of blood or saliva. The sample is then analyzed in a laboratory to identify specific genetic variations in the CYP2C19 gene.

Benefits of the test

The results of the test can help healthcare providers personalize medication dosages and treatment plans based on an individual’s genetic profile. The test is particularly important for medications with a narrow therapeutic index, where small changes in drug metabolism can significantly impact treatment outcomes. It can also be useful in identifying individuals who may be at an increased risk of adverse drug reactions or treatment failure.

Who should consider the test?

It is important to note that the CYP2C19 genotyping test is not routinely performed on everyone. It is typically reserved for individuals who are receiving or are about to receive medications that are known to be metabolized by the CYP2C19 enzyme. The test results should be interpreted by a healthcare professional who can take into account the individual’s medical history, other medications being taken, and other relevant factors.

Test Name CYP2C19 GENOTYPING Test
Components
Price 1850.0 AED
Sample Condition 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery SampleSat by 11 am;Report 15 Working days
Method PCR, Sequencing
Test type Pharmacogenomics
Doctor Physician
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details

CYP2C19 genotyping test is a genetic test that determines an individual’s specific genetic variations in the CYP2C19 gene. This gene encodes an enzyme that is responsible for metabolizing various drugs, including antiplatelet agents, antidepressants, and proton pump inhibitors.

The test is usually performed to identify individuals who may have variations in the CYP2C19 gene, which can affect how they metabolize certain medications. These genetic variations can result in either decreased or increased enzyme activity, leading to variations in drug response and potential adverse effects.

The CYP2C19 genotyping test is typically done using a sample of blood or saliva. The sample is then analyzed in a laboratory to identify specific genetic variations in the CYP2C19 gene. The results of the test can help healthcare providers personalize medication dosages and treatment plans based on an individual’s genetic profile.

The test is particularly important for medications with a narrow therapeutic index, where small changes in drug metabolism can significantly impact treatment outcomes. It can also be useful in identifying individuals who may be at an increased risk of adverse drug reactions or treatment failure.

It is important to note that the CYP2C19 genotyping test is not routinely performed on everyone. It is typically reserved for individuals who are receiving or are about to receive medications that are known to be metabolized by the CYP2C19 enzyme. The test results should be interpreted by a healthcare professional who can take into account the individual’s medical history, other medications being taken, and other relevant factors.